Malcolm R. Hill's most recent trade in Evoke Pharma Inc was a trade of 5,833 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 28, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Evoke Pharma Inc | Malcolm R. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 5,833 | 5,833 | - | - | Stock Option (Right to Buy) | |
Evoke Pharma Inc | Malcolm R. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 14,625 | 14,625 | - | - | Stock Option (Right to Buy) | |
Evoke Pharma Inc | Malcolm R. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 14,625 | 14,625 | - | - | Stock Option (Right to Buy) | |
Evoke Pharma Inc | Malcolm R. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2022 | 57,750 | 57,750 | - | - | Stock Option (Right to Buy) | |
Evoke Pharma Inc | Malcolm R. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2020 | 54,000 | 54,000 | - | - | Stock Option (Right to Buy) |